A committee of the Institute of Medicine concludes that the Food and Drug Administration's 510(k) process for approving medical devices deemed to have a moderate risk to patients needs not to be reworked, but replaced.
IOM studied the 510(k) issue at the request of the FDA. The committee was asked to answer two questions:
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access